PETER JINDRA to Transplantation, Homologous
This is a "connection" page, showing publications PETER JINDRA has written about Transplantation, Homologous.
Connection Strength
0.357
-
The outcome of allogeneic HSCT in older AML patients is determined by disease biology and not by the donor type: an analysis of 96 allografted AML patients = 50 years from the Czech acute leukaemia clinical register (alert). Neoplasma. 2013; 60(5):576-83.
Score: 0.087
-
Tolerance to MHC class II disparate allografts through genetic modification of bone marrow. Gene Ther. 2013 May; 20(5):478-86.
Score: 0.084
-
Induction of transplantation tolerance to fully mismatched cardiac allografts by T cell mediated delivery of alloantigen. Clin Immunol. 2010 Aug; 136(2):174-87.
Score: 0.072
-
Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT. Bone Marrow Transplant. 2024 02; 59(2):224-231.
Score: 0.046
-
Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2014 Mar; 49(3):389-96.
Score: 0.023
-
Haematological malignancies in sibling and unrelated donors of allogeneic peripheral stem cells mobilised with G-CSF filgrastim: a transplant centre and Czech National Marrow Donors Registry experience. Bone Marrow Transplant. 2012 Jun; 47(6):867-8.
Score: 0.020
-
Phosphorylated S6 ribosomal protein: a novel biomarker of antibody-mediated rejection in heart allografts. Am J Transplant. 2006 Jul; 6(7):1560-71.
Score: 0.014
-
Allogeneic BMT in patients above 45 years of age: a single center experience. Bone Marrow Transplant. 2001 Apr; 27(7):723-6.
Score: 0.010